ENTA Stock Analysis: Buy, Sell, or Hold?
ENTA - Enanta Pharmaceuticals, Inc
$11.58
-0.32 (-2.69%)
▼
5d:
+4.61%
30d:
-16.15%
90d:
-10.3%
BUY
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When ENTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ENTA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ENTA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ENTA is currently trading at $11.58, which is considered oversold relative to its 30-day fair value range of $11.72 to $14.32.
Technical Outlook: Technically, ENTA is showing sideways momentum. Immediate support is located at $10.86, while resistance sits at $13.85.
Market Sentiment: ENTA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.14 (+69.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ENTA is showing sideways momentum. Immediate support is located at $10.86, while resistance sits at $13.85.
Market Sentiment: ENTA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.14 (+69.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$11.72 -
$14.32
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 69.3% below Wall St target ($20.14)
Trading Range Analysis
30-Day Trading Range
$11.72 -
$14.32
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.05
(9.1%)
Support & Resistance Levels
Support Level
$10.86
Resistance Level
$13.85
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.09
Wall Street Target
$20.14
(+69.3%)
Revenue Growth (YoY)
15.0%
Earnings Growth (YoY)
-66.2%
Profit Margin
-89.6%
Share & Embed Analysis
Last updated: June 15, 2026 3:07 PM ET
Data refreshes hourly during market hours. Next update: 4:07 PM
Data refreshes hourly during market hours. Next update: 4:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$102 | 58 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 55 HOLD |
Advanced ENTA Option Strategies
Professional options setups generated by AI based on today's ENTA price and gamma walls.
